Feasibility study of a personalized tumor membrane vesicle vaccine immunotherapy for head and neck squamous cell carcinoma (HNSCC)

被引：0
|
作者：
Bommireddy, Ramireddy
Pack, Christopher D.
Ramachandiran, Sampath
Jacobsen, Kristen
Reddy, Shaker J. C.
Schmitt, Nicole C.
Patel, Mihir R.
Shi, Qiuying
Steuer, Conor Ernst
Saba, Nabil F.
Selvaraj, Periasamy
Shin, Dong Moon
机构：
[1] Emory Univ, Atlanta, GA USA
[2] Metaclipse Therapeut Corp, Atlanta, GA USA
[3] Emory Univ, Winship Canc Inst, Dept Otolaryngol Head & Neck Surg, Atlanta, GA USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14673
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor membrane vesicle-based vaccine immunotherapy inhibits tumor growth and metastasis of squamous cell carcinoma of head and neck in mice
    Bommireddy, Ramireddy
    Munoz, Luis E.
    Pack, Chrstopher
    Ramachandiran, Sampath
    Reddy, Shaker
    Chen, Georgia
    Saba, Nabil
    Shin, Dong M.
    Selvaraj, Periasamy
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [2] Tumor membrane vesicle-based vaccine inhibits growth of squamous cell carcinoma of head and neck in mice
    Bommireddy, R.
    Munoz, L.
    Pack, C.
    Ramachandiran, S.
    Reddy, S.
    Kim, J.
    Chen, G.
    Saba, N.
    Shin, D.
    Selvaraj, P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1693 - 1693
  • [3] Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, J. M.
    Ferris, R. L.
    JOURNAL OF DENTAL RESEARCH, 2018, 97 (06) : 622 - 626
  • [4] Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
    Shan, Yidan
    He, Di
    Yan, Fengguo
    Huang, Weijia
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [5] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
    Cohen, Ezra E. W.
    Bell, R. Bryan
    Bifulco, Carlo B.
    Burtness, Barbara
    Gillison, Maura L.
    Harrington, Kevin J.
    Quynh-Thu Le
    Lee, Nancy Y.
    Leidner, Rom
    Lewis, Rebecca L.
    Licitra, Lisa
    Mehanna, Hisham
    Mel, Loren K.
    Raben, Adam
    Sikora, Andrew G.
    Uppaluri, Ravindra
    Whitworth, Fernanda
    Zandberg, Dan P.
    Ferris, Robert L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma
    Zolkind, Paul
    Dunn, Gavin P.
    Lin, Tianxiang
    Griffith, Malachi
    Griffith, Obi L.
    Uppaluri, Ravindra
    ORAL ONCOLOGY, 2017, 71 : 169 - 176
  • [7] The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications
    Economopoulou, Panagiota
    Perisanidis, Christos
    Giotakis, Evaggelos I.
    Psyrri, Amanda
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (09)
  • [8] HNSCC Ecotypes: Tumor Immune Microenvironment Subtypes of Head and Neck Squamous Cell Carcinoma
    Unger, Kristian
    Hess, Julia
    Baumeister, Philipp
    Lauber, Kirsten
    Klauschen, Frederick
    Canis, Martin
    Zitzelsberger, Horst
    Belka, Claus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S6 - S6
  • [9] Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
    Economopoulou, Panagiota
    de Bree, Remco
    Kotsantis, Ioannis
    Psyrri, Amanda
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Weller, Patrick
    Nel, Ivonne
    Hassenkamp, Philipp
    Gauler, Thomas
    Schlueter, Anke
    Lang, Stephan
    Dountsop, Paulette
    Hoffmann, Andreas-Claudius
    Lehnerdt, Goetz
    PLOS ONE, 2014, 9 (12):
12345